IMARC Group, a leading market research company, has recently releases report titled “Australia MedTech Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The Australia MedTech market size reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.
Factors Affecting the Growth of Australia MedTech Industry:
- Increasing Healthcare Expenditure and Aging Population:
The healthcare expenditure of Australia has been steadily rising due to an aging population. As individuals age, they tend to require more medical attention and treatments. This demographic shift has led to a rise in the demand for MedTech devices and solutions. From diagnostics to home care devices, the MedTech sector is thriving as it caters to the healthcare needs of the elderly. This factor is reinforced by the commitment of the Australian government to funding healthcare, making it easier for patients to access MedTech innovations.
- Significant Advancements in Technology and Research:
Australia has been a hub for innovative research and development in the MedTech sector. The commitment of the country to cutting-edge technology and scientific breakthroughs has resulted in significant advancements. One key area of focus has been the development of wearable health monitoring devices. These devices enable individuals to track their vital signs and health metrics, promoting proactive healthcare management. Australian companies have excelled in creating wearable devices that cater to various healthcare needs, from heart rate monitoring to glucose level tracking. Furthermore, 3D printing technology has played a pivotal role in the growth of the MedTech sector. It has revolutionized the production of prosthetic limbs and customized medical implants. Australian researchers and manufacturers have harnessed capabilities of 3D printing to create patient-specific solutions, enhancing the quality of life for those in need of such devices. This innovation benefits the domestic market and also opens up export opportunities, as Australian-made medical devices gain recognition for their precision and quality worldwide.
- Regulatory Framework and Market Access:
The strong regulatory framework of for medical devices has been instrumental in fostering trust and innovation within the MedTech industry. The Therapeutic Goods Administration (TGA) oversees the regulation of medical devices, ensuring that they meet strict safety and efficacy standards. This rigorous oversight instills confidence in both consumers and healthcare professionals, facilitating the adoption of MedTech solutions. The well-defined regulatory pathway for medical devices in Australia also makes it easier for companies to bring their products to market. The TGA provides clear guidelines and a transparent approval process, reducing regulatory hurdles and time-to-market for new innovations. This regulatory efficiency encourages domestic and international companies to invest in the Australian MedTech market.
Leading Companies Operating in the Australia MedTech Industry:
- Alcidion Group Limited
- Anatomics Pty Ltd
- Artrya
- AusBiotech
- Avanade Australia (Accenture)
- Cochlear Limited
- Ellex
- ResMed Inc.
- Schott AG
- Sirtex Medical Limited
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/australia-medtech-market/requestsample
Australia MedTech Market Report Segmentation:
By Type:
- Telehealth
- Medical Wearables
- EMR/EHR Systems
- Medical Apps
- Healthcare Analytics
- Others
Based on the type, the market has been divided into telehealth, medical wearables, EMR/EHR systems, medical apps, healthcare analytics, and others.
By Component:
- Software
- Hardware
- Service
On the basis of the component, the market has been segmented into software, hardware, and service.
By Deployment Type:
- On-Premises
- Cloud-Based
Based on the deployment type, the market has been segregated into on-premises and cloud-based.
By Application:
- Cardiology
- Diabetes
- Neurology
- Sleep Apnea
- Oncology
- Others
On the basis of the application, the market has been categorized into cardiology, diabetes, neurology, sleep apnea, oncology, and others.
By End User:
- Healthcare Providers
- Healthcare Payers
- Pharmaceutical Companies
Based on the end user, the market has been divided into healthcare providers, healthcare payers, and pharmaceutical companies.
Regional Insights:
- Western Australia
- New South Wales
- Queensland
- Victoria
- Rest of Australia
Region-wise, the market has been classified into Western Australia, New South Wales, Queensland, Victoria, Rest of Australia.
Australia MedTech Market Trends:
Australia possesses a robust network of academic and research institutions dedicated to healthcare and medical technology. These institutions actively collaborate with the private sector, fostering innovation and knowledge exchange. Partnerships between universities, research centers, and MedTech companies have led to groundbreaking discoveries and the development of new medical technologies. This synergy between academia and industry accelerates the growth of the MedTech sector in Australia. Additionally, the Australian government recognizes the importance of the MedTech industry and has implemented various initiatives to support its growth. One such initiative is the Medical Research Future Fund (MRFF), which allocates significant funding to medical research and innovation. Additionally, programs, such as the R&D Tax Incentive encourage companies to invest in research and development activities, further promoting innovation in the MedTech sector. These government-backed incentives create a favorable environment for companies to invest in cutting-edge technologies and product development.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
Street: Morgan Park QLD 4370
City/Town: Warwick
State/Province/Region: Queensland
Country: Australia
Zip/Postal Code: 4370
Email: sales@imarcgroup.com
Phone Number: +1-631-791-1145
